Goldman Sachs’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $8.24K | Sell |
|
|||||
|
2023
Q1 | $237K | Buy |
|
|||||
|
2022
Q4 | $201K | Sell |
|
|||||
|
2022
Q3 | $1.52M | Sell |
|
|||||
|
2022
Q2 | $1.62M | Sell |
|
|||||
|
2022
Q1 | $2.24M | Sell |
|
|||||
|
2021
Q4 | $2M | Buy |
|
|||||
|
2021
Q3 | $2.54M | Sell |
|
|||||
|
2021
Q2 | $3.54M | Sell |
|
|||||
|
2021
Q1 | $4.5M | Sell |
|
|||||
|
2020
Q4 | $6.73M | Buy |
|
|||||
|
2020
Q3 | $3.52M | Buy |
|
|||||
|
2020
Q2 | $2.84M | Buy |
|
|||||
|
2020
Q1 | $409K | Sell |
|
|||||
|
2019
Q4 | $1.61M | Buy |
|
|||||
|
2019
Q3 | $1.04M | Buy |
|
|||||
|
2019
Q2 | $345K | Sell |
|
|||||
|
2019
Q1 | $919K | Buy |
|
|||||
|
2018
Q4 | $443K | Buy |
|
|||||
|
2018
Q3 | $130K | Sell |
|
|||||
|
2018
Q2 | $169K | Buy |
|
|||||
|
2018
Q1 | $116K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $272K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $60K | Buy |
|
|||||
|
2015
Q3 | $42K | Sell |
|
|||||
|
2015
Q2 | $71K | Buy |
|
|||||
|
2015
Q1 | $319K | Buy |
|
|||||
|
2014
Q4 | $279K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $219K | Sell |
|
|||||
|
2014
Q1 | $403K | Buy |
|